A System-Based Patient-Centered Approach to HER2-Positive Breast Cancer

Title:

A System-Based Patient-Centered Approach to HER2-Positive Breast Cancer

Topic: Oncology
Relevant Terms: Breast cancer, HER2
Primary Audience: Oncology clinicians, including physicians, nurses, nurse practitioners, and physician assistants
Launch Date: 20-Feb-18
Credits: 0.5 AMA PRA Category 1 Credit
0.5 ANCC contact hour
Expiration Date: 20-Feb-19
Curriculum Name: A System-Based Patient-Centered Approach to HER2-Positive Breast Cancer

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Routinely use ASCO/CAP13 guidelines to determine HER2 status that guide management and assist in evaluating risk 
  2. Integrate evolving targeted treatment paradigms into clinical practice for patients with HER2-positive breast cancer, based on efficacy and safety 
  3. Utilize evidence-based and guideline recommendations for neoadjuvant and adjuvant treatments and appropriate treatment sequencing strategies for patients with HER2-positive breast cancer 
  4. Develop a strong patient-provider collaborative approach to managing patients with breast cancer that includes multidisciplinary management, patient education, engagement, and shared decision making 

    Faculty

    Hope S. Rugo, MD, FASCO
    Professor of Medicine
    Director, Breast Oncology and Clinical Trials Education
    University of California San Francisco
    Helen Diller Family Comprehensive Cancer Center
    San Francisco, CA
    Joint Accreditation Statement
     
     
     
     
    In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RMEI Medical Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Physician Continuing Medical Education
    The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Continuing Nursing Education
    The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hour.
    Designated for 0.5 contact hour of pharmacotherapy credit for Advance Practice Registered Nurses.


    DISCLOSURE OF CONFLICTS OF INTEREST
    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Hope S. Rugo, MD, has affiliations with Eisai, Genentech, Lilly, Macrogenics, Merck, Novartis, OBI Pharma, Pfizer, and Plexxikon – all funding to UC Regents only (Contracted Research).

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    RMEI Medical Education, LLC
    Carrie Noriega, MD, has no affiliations with commercial interests to disclose.
    Lobna M. Eldasher, PharmD, has no affiliations with commercial interests to disclose.
    Sharon Powell, has no affiliations with commercial interests to disclose.

    Postgraduate Institute for Medicine
    Planners and Managers
    The PIM planners and managers, Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, MBA, MSN, RN; and Jan Schultz, MSN, RN, CHCP, have nothing to disclose.
     
    DISCLAIMER
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
     
    DISCLOSURE OF UNLABELED USE
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
     
    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
     
    Estimated Time to Complete: 30 minutes
     
    Media
    Internet
     
    FEE INFORMATION
    There is no fee for this educational activity.
     
    STATEMENT OF COMMERCIAL SUPPORT
    This activity is supported by an educational grant from Genentech.
     
    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, registered nurses, and physician assistants are entitled to receive up to 0.5 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
     
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the activity evaluation.
    Physicians, nurse practitioners, registered nurses, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above
     
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above.